Edgemont launches new higher dose bupropion extended-release tablets
The Forfivo XL, which the company claims, is the only available 450mg dose of an extended-release bupropion product and is intended for the treatment of major depressive disorder
The European Commission (EC) has approved an extended use of Johnson & Johnson’s Tecvayli (teclistamab), along with daratumumab, to treat adult patients with relapsed or refractory multiple myeloma (r/r MM).
Magnesium-enriched SoyLife product, which is produced by Israel-based Frutarom company, is a proprietary soy germ extract designed to support well-being of women experiencing menopausal symptoms. Multiple scientific studies